Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Commentary

Type 2 Diabetes is a Preventable, Possibly Remittable, and Mostly Controllable Disease: The Time to Change the Paradigm

Author(s): Mervat M. El-Eshmawy*

Volume 23, Issue 2, 2023

Published on: 20 August, 2022

Page: [247 - 249] Pages: 3

DOI: 10.2174/1871530322666220430012050

« Previous Next »
[1]
Ogurtsova, K.; da Rocha Fernandes, J.D.; Huang, Y.; Linnenkamp, U.; Guariguata, L.; Cho, N.H.; Cavan, D.; Shaw, J.E.; Makaroff, L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract., 2017, 128, 40-50.
[http://dx.doi.org/10.1016/j.diabres.2017.03.024] [PMID: 28437734]
[2]
Smushkin, G.; Vella, A. Genetics of type 2 diabetes. Curr. Opin. Clin. Nutr. Metab. Care, 2010, 13(4), 471-477.
[http://dx.doi.org/10.1097/MCO.0b013e32833a558d ] [PMID: 20473152]
[3]
Franks, P.W.; McCarthy, M.I. Exposing the exposures re-sponsible for type 2 diabetes and obesity. Science, 2016, 354(6308), 69-73.
[http://dx.doi.org/10.1126/science.aaf5094] [PMID: 27846494]
[4]
American Diabetes Association. 5. Prevention or delay of type 2 diabetes: Standards of medical care in diabetes-2018. Diabetes Care, 2018, 41(Suppl. 1), S51-S54.
[http://dx.doi.org/10.2337/dc18-S005] [PMID: 29222376]
[5]
American Diabetes Association Standards of medical care in diabetes-2019 abridged for primary care providers. Clin. Diabetes, 2019, 37(1), 11-34.
[http://dx.doi.org/10.2337/cd18-0105] [PMID: 30705493]
[6]
WHO Global report on diabetes, 2016. Available from: http://www.who.int/diabetes/global-report/en/ (Accessed on Nov 20, 2017)
[7]
Pan, X.R.; Li, G.W.; Hu, Y.H.; Wang, J.X.; Yang, W.Y.; An, Z.X.; Hu, Z.X.; Lin, J.; Xiao, J.Z.; Cao, H.B.; Liu, P.A.; Jiang, X.G.; Jiang, Y.Y.; Wang, J.P.; Zheng, H.; Zhang, H.; Bennett, P.H.; Howard, B.V. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 1997, 20(4), 537-544.
[http://dx.doi.org/10.2337/diacare.20.4.537] [PMID: 9096977]
[8]
Torgerson, J.S.; Hauptman, J.; Boldrin, M.N.; Sjöström, L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004, 27(1), 155-161.
[http://dx.doi.org/10.2337/diacare.27.1.155] [PMID: 14693982]
[9]
Garvey, W.T.; Ryan, D.H.; Henry, R.; Bohannon, N.J.; Toplak, H.; Schwiers, M.; Troupin, B.; Day, W.W. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care, 2014, 37(4), 912-921.
[http://dx.doi.org/10.2337/dc13-1518] [PMID: 24103901]
[10]
Sjöström, L.; Lindroos, A.K.; Peltonen, M.; Torgerson, J.; Bouchard, C.; Carlsson, B.; Dahlgren, S.; Larsson, B.; Narbro, K.; Sjöström, C.D.; Sullivan, M.; Wedel, H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med., 2004, 351(26), 2683-2693.
[http://dx.doi.org/10.1056/NEJMoa035622] [PMID: 15616203]
[11]
Rubino, F.; Nathan, D.M.; Eckel, R.H.; Schauer, P.R.; Alberti, K.G.; Zimmet, P.Z.; Del Prato, S.; Ji, L.; Sadikot, S.M.; Herman, W.H.; Amiel, S.A.; Kaplan, L.M.; Taroncher-Oldenburg, G.; Cummings, D.E.; Albache, N.; Batterham, R.L.; Bhatt, D.L.; Boza, C.; Cefalu, W.T.; Cohen, R.V.; Courcoulas, A.P.; Dinneen, S.F.; Dixon, J.B.; Ferrannini, E.; Fioretto, P.; Frühbeck, G.; Gagner, M.; Grant, R.W.; Ikramuddin, S.; Johnston, D.G.; Kashyap, S.R.; Kelly, T.; Klupa, T.; Korner, J.; Laferrère, B.; Lebovitz, H.E.; Lee, W-J.; le Roux, C.W.; Mechanick, J.I.; Mingrone, G.; Morton, J.M.; Pories, W.J.; Ratner, R.E.; Rayman, G.; Sugerman, H.J.; Van Gaal, L.; Vidal, J.; Weng, J.; Wolfe, B.M. Metabolic surgery in the treatment algorithm for type 2 diabetes: A joint statement by international diabetes organizations. Diabetes Care, 2016, 39(6), 861-877.
[http://dx.doi.org/10.2337/dc16-0236] [PMID: 27222544]
[12]
World Health Organization. Global report on diabetes. 2016. Available from: https://www.who.int/diabetes/publications/grd-2016/en/
[13]
Steven, S.; Lim, E.L.; Taylor, R. Population response to information on reversibility of Type 2 diabetes. Diabet. Med., 2013, 30(4), e135-e138.
[http://dx.doi.org/10.1111/dme.12116] [PMID: 23320491]
[14]
Lean, M.E.; Leslie, W.S.; Barnes, A.C.; Brosnahan, N.; Thom, G.; McCombie, L.; Peters, C.; Zhyzhneuskaya, S.; Al-Mrabeh, A.; Hollingsworth, K.G.; Rodrigues, A.M.; Rehackova, L.; Adamson, A.J.; Sniehotta, F.F.; Mathers, J.C.; Ross, H.M.; McIlvenna, Y.; Stefanetti, R.; Trenell, M.; Welsh, P.; Kean, S.; Ford, I.; McConnachie, A.; Sattar, N.; Taylor, R. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet, 2018, 391(10120), 541-551.
[http://dx.doi.org/10.1016/S0140-6736(17)33102-1] [PMID: 29221645]
[15]
Lean, M.E.J.; Leslie, W.S.; Barnes, A.C.; Brosnahan, N.; Thom, G.; McCombie, L.; Peters, C.; Zhyzhneuskaya, S.; Al-Mrabeh, A.; Hollingsworth, K.G.; Rodrigues, A.M.; Rehackova, L.; Adamson, A.J.; Sniehotta, F.F.; Mathers, J.C.; Ross, H.M.; McIlvenna, Y.; Welsh, P.; Kean, S.; Ford, I.; McConnachie, A.; Messow, C.M.; Sattar, N.; Taylor, R. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the Di-RECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol., 2019, 7(5), 344-355.
[http://dx.doi.org/10.1016/S2213-8587(19)30068-3] [PMID: 30852132]
[16]
Min, T.; Barry, J.D.; Stephens, J.W. Predicting the resolution of type 2 diabetes after bariatric surgical procedures: A con-cise review. J. Diabetes Metab., 2015, 6, 617.
[17]
Taylor, R.; Al-Mrabeh, A.; Zhyzhneuskaya, S.; Peters, C.; Barnes, A.C.; Aribisala, B.S.; Hollingsworth, K.G.; Mathers, J.C.; Sattar, N.; Lean, M.E.J. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for beta cell recovery. Cell Metab., 2018, 28(4), 547-556.e3.
[http://dx.doi.org/10.1016/j.cmet.2018.07.003] [PMID: 30078554]
[18]
Purnell, J.Q.; Selzer, F.; Wahed, A.S.; Pender, J.; Pories, W.; Pomp, A.; Dakin, G.; Mitchell, J.; Garcia, L.; Staten, M.A.; McCloskey, C.; Cummings, D.E.; Flum, D.R.; Courcoulas, A.; Wolfe, B.M. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: Results of the longitudinal assessment of bariatric surgery study. Diabetes Care, 2016, 39(7), 1101-1107.
[http://dx.doi.org/10.2337/dc15-2138] [PMID: 27289123]
[19]
Salminen, P.; Helmiö, M.; Ovaska, J.; Juuti, A.; Leivonen, M.; Peromaa-Haavisto, P.; Hurme, S.; Soinio, M.; Nuutila, P.; Victorzon, M. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Rouxen-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: The SLEEVEPASS randomized clinical trial. JAMA, 2018, 319(3), 241-254.
[http://dx.doi.org/10.1001/jama.2017.20313] [PMID: 29340676]
[20]
International Diabetes Federation.IDF clinical practice recommendations for managing type 2 diabetes in primary care. Available from:https://www.idf.org/elibrary/guidelines/128-idf-clinical-practice-recommendations-for managing-type-2-diabetes-in-primarycare.html (Accessed on Nov 20, 2017).

Rights & Permissions Print Cite
Article Metrics
20
1
© 2024 Bentham Science Publishers | Privacy Policy